from www.theflyonthewall.com:
>>Soleil reiterates a Sell rating on Accuray, saying its consultant is skeptical of a journal article on Accuray's CyberKnife System in prostate cancer
Thursday, January 20, 2011
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment